Dyne Therapeutics, Inc.

DYN - Company ID 0001818794

Market cap$4.01 B

Rank#1602

Filings703

Dyne Therapeutics, Inc. has filed 703 public company documents between 2020 and 2026. The most frequent type is insider trade (299 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchDYN overview$4.01 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1602See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut DYN beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow DYN via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
S-8	Employee stock plan	3mo ago2026-03-27	-	View filing
S-8	Employee stock plan	4mo ago2026-03-02	-	View filing
S-8	Employee stock plan	1y ago2025-03-27	-	View filing
S-8	Employee stock plan	1y ago2025-02-27	-	View filing
S-8	Employee stock plan	2y ago2024-05-02	-	View filing
S-8	Employee stock plan	2y ago2024-03-05	-	View filing
S-8	Employee stock plan	3y ago2023-03-02	-	View filing
S-8	Employee stock plan	4y ago2022-03-10	-	View filing
S-8	Employee stock plan	5y ago2021-03-04	-	View filing
S-8	Employee stock plan	5y ago2020-09-17	-	View filing

Dyne Therapeutics, Inc.

Similar companies to research next

Year